Evolv Technology Reports Third Quarter Financial Results
Evolv Technologies Holdings, Inc. (EVLV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Evolv Technology Reports Third Quarter Financial Results • Q3'26 Revenue of $47.3 million, up 10% year-over-year • Q3'26 Ending ARR 1 of $140.5 million, up 20% year-over-year • Q3'26 Net Loss of $(15.6) million, with Net Profit Margin of (32.9)% • Q3'26 Adjusted EBIT
How this was made
The 30-second read
Why it matters
The new guidance sets expectations for 2026 revenue of $182‑185M and EBITDA of $15.5‑$16.5M, which may influence valuation models.
Market read
First‑hand earnings and guidance release for a micro‑cap security tech firm; relevant for niche investors.
What to watch
Cash position of $66.9M and strong ARR growth could support longer‑term upside.
Q3 2026 revenue up 10% to $47.3 million and ARR up 20% to $140.5 million, while GAAP net loss widened to $(15.6) million and Adjusted EBITDA slipped to $4.7 million
Top-line and ARR growth accelerated against a prior-year quarter that included the largest contract in company history, and nine-month revenue rose 28%. Offsetting this, the GAAP net loss widened from $(1.8) million to $(15.6) million, General and administrative expense rose from $12,579 thousand to $18,657 thousand, and Adjusted EBITDA fell from $5.1 million to $4.7 million. The FY2026 revenue range was narrowed upward at the low end, while the Adjusted EBITDA range was moved up.
Actuals vs. the company’s prior outlook
from its previous release| Metric | Guided | Reported | Verdict |
|---|---|---|---|
| Total revenue, FY2026 | $180 million to $185 million (issued August 11, 2026) | Full-year actual not yet reported. Updated range issued November 10, 2026: $182 million to $185 million | n/a |
| Ending ARR at 12/31/26 | $148 million to $150 million (issued August 11, 2026) | Year-end actual not yet reported. Range issued November 10, 2026: $148 million to $150 million | n/a |
| Adjusted EBITDA, FY2026 | $15 million to $16 million (issued August 11, 2026) | Full-year actual not yet reported. Updated range issued November 10, 2026: $15.5 million to $16.5 million | n/a |
| Adjusted EBITDA margin, FY2026 | High single digits (issued August 11, 2026) | Full-year actual not yet reported. Range issued November 10, 2026: high single digits | n/a |
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total revenue, Q3 2026GAAP | $47.3M | – | 10% |
| Product revenue, Q3 2026GAAP | $12.33M | – | – |
| Subscription revenue, Q3 2026GAAP | $24.49M | – | – |
| Service revenue, Q3 2026GAAP | $9.51M | – | – |
| License fee and other revenue, Q3 2026GAAP | $1.02M | – | – |
| Total cost of revenue, Q3 2026GAAP | $23.80M | – | – |
| Gross profit, Q3 2026GAAP | $23.55M | – | – |
| Gross margin, Q3 2026GAAP | 49.7% | – | – |
| Adjusted gross profit, Q3 2026non-GAAP | $24.07M | – | – |
| Adjusted gross margin, Q3 2026non-GAAP | 50.8% | – | – |
| Research and development, Q3 2026GAAP | $6.13M | – | – |
| Sales and marketing, Q3 2026GAAP | $13.17M | – | – |
| General and administrative, Q3 2026GAAP | $18.66M | – | – |
| Restructuring costs, Q3 2026GAAP | none printed (shown as a dash) | – | – |
| Total operating expenses, Q3 2026GAAP | $37.95M | – | – |
| Loss from operations, Q3 2026GAAP | −$14.40M | – | – |
| Adjusted loss from operations, Q3 2026non-GAAP | −$2.48M | – | – |
| Interest expense, Q3 2026GAAP | −$982K | – | – |
| Interest income, Q3 2026GAAP | $540K | – | – |
| Loss before income taxes, Q3 2026GAAP | −$15.56M | – | – |
| Net loss, Q3 2026GAAP | −$15.6M | – | – |
| Net loss per share, basic and diluted, Q3 2026GAAP | $(0.09) per basic and diluted share | – | – |
| Net profit margin, Q3 2026non-GAAP | (32.9)% | – | – |
| Adjusted loss, Q3 2026non-GAAP | −$2.94M | – | – |
| Adjusted loss per diluted share, Q3 2026non-GAAP | $(0.02) per diluted share | – | – |
| Adjusted EBITDA, Q3 2026non-GAAP | $4.7M | – | – |
| Adjusted EBITDA margin, Q3 2026non-GAAP | 10.0% | – | – |
| Stock-based compensation, Q3 2026GAAP | $6.93M | – | – |
| Depreciation and amortization, Q3 2026GAAP | $7.48M | – | – |
| Annual Recurring Revenue (ARR), end of Q3 2026other | $140.5M | – | 20% |
| Recurring revenue, Q3 2026other | $32.55M | – | – |
| Recurring revenue as % of total revenue, Q3 2026other | 69% | – | – |
| Non-recurring revenue, Q3 2026other | $14.80M | – | – |
| New customers, Q3 2026other | 51 | – | – |
| Remaining Performance Obligation, end of Q3 2026other | $325.8M | up $13.2 million sequentially | – |
| Cash, cash equivalents and marketable securities, end of Q3 2026other | $66.9M | up $3.5 million sequentially | – |
| Operating cash flow, Q3 2026GAAP | $17.96M | – | – |
| Free cash flow, Q3 2026non-GAAP | $3.25M | – | – |
| Total revenue, nine months 2026GAAP | $137.4M | – | 28% |
| Product revenue, nine months 2026GAAP | $34.86M | – | – |
| Subscription revenue, nine months 2026GAAP | $72.42M | – | – |
| Service revenue, nine months 2026GAAP | $27.06M | – | – |
| License fee and other revenue, nine months 2026GAAP | $3.08M | – | – |
| Gross profit, nine months 2026GAAP | $69.1M | – | – |
| Gross margin, nine months 2026GAAP | 50.3% | – | – |
| Adjusted gross margin, nine months 2026non-GAAP | 51.3% | – | – |
| Total operating expenses, nine months 2026GAAP | $102.5M | – | – |
| Research and development, nine months 2026GAAP | $17.79M | – | – |
| Sales and marketing, nine months 2026GAAP | $38.53M | – | – |
| General and administrative, nine months 2026GAAP | $46.20M | – | – |
| Loss from operations, nine months 2026GAAP | −$33.42M | – | – |
| Adjusted loss from operations, nine months 2026non-GAAP | −$7.90M | – | – |
| Net loss, nine months 2026GAAP | −$29.9M | – | – |
| Net loss per share, basic and diluted, nine months 2026GAAP | $(0.17) per basic and diluted share | – | – |
| Adjusted loss, nine months 2026non-GAAP | −$9.30M | – | – |
| Adjusted loss per diluted share, nine months 2026non-GAAP | $(0.05) per diluted share | – | – |
| Adjusted EBITDA, nine months 2026non-GAAP | $13.1M | – | – |
| Adjusted EBITDA margin, nine months 2026non-GAAP | 9.5% | – | – |
| Net cash provided by operating activities, nine months 2026GAAP | $26.68M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Product revenue (Q3 2026)The filing prints the line and its prior-year figure of $9,242 thousand but gives no driver explanation. | $12.33M | – | – |
| Subscription revenue (Q3 2026)The filing prints the line and its prior-year figure of $22,685 thousand but gives no driver explanation. | $24.49M | – | – |
| Service revenue (Q3 2026)The filing prints the line and its prior-year figure of $7,808 thousand but gives no driver explanation. | $9.51M | – | – |
| License fee and other revenue (Q3 2026)The filing prints the line and its prior-year figure of $3,115 thousand but gives no driver explanation. | $1.02M | – | – |
| Recurring revenue (Q3 2026)The filing prints the classification and its prior-year figure of $28,684 thousand but gives no driver explanation. | $32.55M | – | – |
| Non-recurring revenue (Q3 2026)The filing prints the classification and its prior-year figure of $14,166 thousand but gives no driver explanation. | $14.80M | – | – |
FY2026 outlook
- Revenue$182 million to $185 million, approximately 25% to 27% year-over-year growth
- NoteEnding ARR at December 31, 2026: approximately $148 million to $150 million, growth of approximately 23% to 25% year-over-year
- NoteAdjusted EBITDA: $15.5 million to $16.5 million, with Adjusted EBITDA margins in the high single digits
- NoteRevenue range is dependent on the mix of new unit deployments between purchase subscription and pure subscription models
- NotePrior outlook issued August 11, 2026: total revenue $180 million to $185 million; ending ARR $148 million to $150 million; Adjusted EBITDA $15 million to $16 million; Adjusted EBITDA margin high single digits
- NoteThe filing prints both the August 11, 2026 and November 10, 2026 ranges. Changes are shown in the printed table only.
Capital returns
- The filing reports no share repurchases and no dividends in the period.
- Proceeds from exercise of stock options: $847 thousand for nine months 2026 versus $8,406 thousand for nine months 2025 (cash flow statement).
- Common shares issued and outstanding rose from 175,399,488 at December 31, 2025 to 181,233,753 at September 30, 2026 (balance sheet).
What drove it
- The CEO attributes the double-digit revenue growth and faster ARR growth to the renewal and expansion motion and the recurring base, and states the prior-year comparison included the largest contract in company history.
- The company states Q3 2026 ARR growth exceeded revenue growth, and cites strong net revenue retention in the quarter without giving a figure.
- The company says its investments in sales capacity and product innovation support its confidence in 2027 and its long-term model of approximately 25% revenue CAGR through 2031, as outlined at Investor Day.
- The filing states the FY2026 revenue range depends on the mix of new unit deployments between purchase subscription and pure subscription models.
- Non-recurring legal and regulatory costs of $4,778 thousand in Q3 2026 are added back to Adjusted EBITDA and Adjusted loss, per the company's reconciliation. The Q3 2025 figure in the same line was $(36) thousand.
Concerns
- GAAP net loss for Q3 2026 was $(15.6) million versus $(1.8) million a year earlier. The filing does not attribute this change to a single cause.
- General and administrative expense rose to $18,657 thousand from $12,579 thousand in the prior-year quarter, while the release gives no explanation for the increase.
- Adjusted EBITDA was $4.7 million versus $5.1 million, and Adjusted EBITDA margin was 10.0% versus 12.0%.
- Q3 2025 included a $7,521 thousand change in fair value of contingent earn-out liability and a $2,178 thousand gain on contingently issuable/returnable stock liability. Q3 2026 shows no earn-out item and a $(255) thousand change on that liability.
- Gross margin was flat at 49.7% year-over-year, and the nine-month gross margin fell from 52.8% to 50.3%.
- Accounts receivable rose to $50,412 thousand from $30,841 thousand at December 31, 2025.
- The forward-looking statements section cites risks related to material weaknesses in internal control over financial reporting and related remediation costs, and to the SEC and Department of Justice matters.
What to watch
- Whether ARR growth of 20% and revenue growth of 10% in Q3 2026 converge, and whether the FY2026 ending ARR range of $148 million to $150 million is reached.
- Full-year revenue against the $182 million to $185 million range, which the company ties to the mix of purchase subscription and pure subscription deployments.
- General and administrative expense trend after the step-up to $18,657 thousand in Q3 2026.
- Quarter-over-quarter progress in Remaining Performance Obligation ($325.8 million) and in cash, cash equivalents and marketable securities ($66.9 million).
- Adjusted EBITDA delivery against the revised $15.5 million to $16.5 million range, given the Q3 2026 figure of $4.7 million.
- Non-recurring legal and regulatory costs, which were $4,778 thousand in Q3 2026 and $5,582 thousand for nine months 2026.
Balance sheet and cash flow
- Cash and cash equivalents: $61,910 thousand at September 30, 2026 versus $49,150 thousand at December 31, 2025.
- Marketable securities: $4,951 thousand at September 30, 2026 versus $19,885 thousand at December 31, 2025.
- Total assets: $303,061 thousand at September 30, 2026 versus $304,409 thousand at December 31, 2025.
- Total liabilities: $195,275 thousand at September 30, 2026 versus $184,987 thousand at December 31, 2025.
- Long-term debt: $28,811 thousand at September 30, 2026 versus $28,596 thousand at December 31, 2025.
- Stockholders' equity: $107,786 thousand at September 30, 2026 versus $119,422 thousand at December 31, 2025.
- Accounts receivable, net: $50,412 thousand at September 30, 2026 versus $30,841 thousand at December 31, 2025.
- Current portion of deferred revenue: $87,385 thousand at September 30, 2026 versus $74,924 thousand at December 31, 2025. Noncurrent deferred revenue: $19,419 thousand versus $16,716 thousand.
- Nine-month purchases of property and equipment: $(25,411) thousand in 2026 versus $(29,109) thousand in 2025. Development of internal-use software: $(4,081) thousand versus $(4,311) thousand.
- Nine-month net cash used in investing activities: $(14,799) thousand in 2026 versus $(43,226) thousand in 2025.
Analysis
Evolv reported Q3 2026 total revenue of $47.3 million, up 10% from $42.9 million, and ending ARR of $140.5 million, up 20% from $117.2 million. The company attributes the slower revenue growth to a prior-year quarter that included its largest contract in history. Within revenue, subscription revenue rose to $24,488 thousand from $22,685 thousand, service revenue to $9,509 thousand from $7,808 thousand, and product revenue to $12,332 thousand from $9,242 thousand, while license fee and other revenue fell to $1,016 thousand from $3,115 thousand. Recurring revenue was $32,548 thousand, or 69% of total revenue, against $28,684 thousand, or 67%, a year earlier. The filing prints recurring revenue of $32,087 thousand and 73% for Q2 2026, so the recurring share moved down sequentially.
Profitability weakened on a GAAP basis. Gross profit was $23,549 thousand and gross margin was 49.7%, flat with the prior-year quarter. Operating expenses rose to $37,951 thousand from $29,902 thousand, led by general and administrative expense of $18,657 thousand against $12,579 thousand. The loss from operations widened to $(14,402) thousand from $(8,596) thousand, and the net loss to $(15.6) million, or $(0.09) per share, from $(1.8) million, or $(0.01) per share. The reconciliation shows $4,778 thousand of non-recurring legal and regulatory costs in Q3 2026. Adjusted loss improved to $(2,938) thousand from $(3,443) thousand, and Adjusted EBITDA was $4.7 million against $5.1 million, with margin at 10.0% against 12.0%. The release does not explain the rise in general and administrative expense.
On a nine-month basis, revenue reached $137.4 million, up 28% from $107.4 million, and product revenue rose to $34,861 thousand from $14,092 thousand. Nine-month Adjusted EBITDA was $13.1 million against $9.3 million, and nine-month net cash provided by operating activities was $26,685 thousand against $3,098 thousand. Cash, cash equivalents and marketable securities were $66.9 million, up $3.5 million sequentially, and Remaining Performance Obligation was $325.8 million, up $13.2 million sequentially. Long-term debt was $28,811 thousand, and the filing shows no share repurchases or dividends.
The guide was reset within a narrow band. FY2026 revenue is now $182 million to $185 million, against $180 million to $185 million issued August 11, 2026, so the low end moved up. Ending ARR is held at $148 million to $150 million. Adjusted EBITDA moved to $15.5 million to $16.5 million from $15 million to $16 million, and the margin outlook is unchanged at high single digits. The company ties the revenue range to the mix of purchase subscription and pure subscription deployments. The filing does not give a full-year actual, so no guidance verdict can yet be drawn. Figures to watch are the widening GAAP loss, the general and administrative step-up, and whether the recurring share of revenue rebuilds from 69%.
Management, verbatim
We delivered double-digit revenue growth, with ARR growing faster than revenue, against a challenging prior-year comparison, as last year's results included the largest contract in our history.
John Kedzierski, President and Chief Executive Officer
Not in the filing
stated, not guessed- Q2 2026 total revenue is not printed in the filing, so sequential revenue change is not available.
- Year-over-year and sequential changes for individual revenue sub-lines, cost lines and operating expense lines are not printed and are not calculated.
- Prior-year and sequential figures for Remaining Performance Obligation and for cash, cash equivalents and marketable securities are not printed.
- Restricted cash amount is named in the headline but no figure is printed for it.
- Segment or geographic revenue breakdown beyond the revenue line types is not provided.
- Full-year FY2026 actuals are not yet reported.
- Consensus estimates, analyst expectations and share-price reaction are not in the documents.
- The filing does not state why general and administrative expense increased.
- Prior-year and sequential changes for recurring and non-recurring revenue amounts are not printed.
- Gross margin, operating expenses and tax rate guidance are not provided for FY2026.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Evolv Technology filed a Form 8‑K reporting its Q3 2026 financial results and outlook for the full year.
Ticker impact
EVLV disclosed Q3 2026 results and 2026 guidance, including $47.3M revenue and $182‑185M full‑year outlook.
likely pressure as market prices in modest revenue growth and continued net losses.
The filing provides fresh earnings numbers and forward guidance, which traders will incorporate into pricing.
Market effects
Provides insight into the AI‑security screening sector's growth trajectory.
Limited to U.S. and North American security technology markets.
Minimal global impact beyond niche security tech investors.
Counterpoint
Despite revenue growth, persistent losses may prompt a sell‑off if investors prioritize profitability.
Key entities
- companyEvolv Technologies Holdings, Inc.
AI‑powered security screening solutions provider.




